Department of Neurology, General Hospital of Northern Theater Command
Shenyang, 110016, China
Location status: Recruiting
NCT Number: NCT07412249
Remote ischemic conditioning (RIC) has emerged as a promising non-invasive strategy to protect the brain, with evidence suggesting its benefit in patients with carotid artery stenting (CAS). However, the long-term benefit and safety of chronic RIC in this population remain unknown. This trial aims to evaluate whether chronic RIC reduces the incidence of major vascular events and improves clinical outcomes in high-risk patients with carotid artery stenosis who received CAS.
Interested in participating?
Request Info40 year and older
All sexes
Interventional
Not applicable
Shenyang, 110016, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The RIC protocol involves bilateral upper-arm cuff inflation to 200 mmHg (5-min inflation/5-min deflation, 5 cycles) performed 1-2 times daily, starting 3 days before CAS and continuing for 12 months post-procedure.
Time frame: 1 year
the composite endpoint includes ischemic stroke, hemorrhagic stroke, myocardial infarction [including coronary revascularization], TIA, or vascular death
Time frame: 30±3 days
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
The minimum and maximum values of mRS are 0 and 6, respectively; higher score mean a worse outcome
Time frame: 1 hours and 24 hours after carotid artery stenting
Time frame: 24 hours after carotid artery stenting
Time frame: 24 hours after carotid artery stenting
General Hospital of Shenyang Military Region
Other
Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis (RICSICAS): A Prospective, Randomized Controlled, Blind Endpoint, Single-Center Study
Acronym: RICSICAS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05566301
Arterial Occlusive Diseases, Brain Diseases
San Donato Milanese, Milan, Italy
View Trial DetailsNCT02748941
Arterial Occlusive Diseases, Brain Diseases
Bron, France
View Trial DetailsNCT07057297
Arterial Occlusive Diseases, Arteriosclerosis
Prague, Czechia
View Trial DetailsNCT01732523
Arterial Occlusive Diseases, Brain Diseases
Basel, Switzerland
View Trial Details